Related Experiment Video
Updated: Apr 19, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
1.1K
Salvage robot-assisted radical prostatectomy with pelvic lymph node dissection after cryotherapy failure
Esequiel Rodriguez1, Douglas W Skarecky1, Thomas E Ahlering1
1UCI Medical Center, Orange, CA USA.
Journal of Robotic Surgery
|December 9, 2014
Summary
This study details the first laparoscopic robotic-assisted radical prostatectomy after cryotherapy for prostate cancer recurrence. The minimally invasive approach showed promising short-term outcomes, including rapid recovery and undetectable PSA levels.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Local recurrence of prostate cancer after cryotherapy presents a treatment challenge.
- Salvage radical prostatectomy is an option, but traditionally performed via open surgery.
Purpose of the Study:
- To report the first case of laparoscopic robotic-assisted salvage radical prostatectomy following cryotherapy for localized prostate cancer recurrence.
- To evaluate the feasibility and initial outcomes of this minimally invasive approach.
Main Methods:
- Laparoscopic radical prostatectomy using the da Vinci robotic system was performed as a salvage procedure.
- Detailed operative parameters, including time and blood loss, were recorded.
- Postoperative recovery, complications, and pathological findings were assessed.
Main Results:
- The procedure was completed in 210 minutes with minimal blood loss (50ml).
- No intraoperative or postoperative complications occurred; hospital stay was 24 hours.
- Pathology revealed extensive disease (pT3bN0, Gleason 5+3) with positive margins.
- The patient achieved pad-free status at 4 weeks and undetectable PSA (<0.1) at 10 months on androgen deprivation therapy.
Conclusions:
- Laparoscopic robotic-assisted salvage radical prostatectomy is a feasible option for local recurrence after cryotherapy.
- This approach offers potential benefits in terms of recovery and complication rates.
- Further research is necessary to validate long-term oncological and functional outcomes.
